The provided figure effectively serves as a visual summary of the therapeutic strategies targeting New York esophageal squamous cell carcinoma (NY‐ESO‐1), a cancer–testis antigen known for its high immunogenicity. Here, CTAG1B is linked to esophageal squamous cell carcinoma.